Safety of hydroxyanthracene derivatives for use in food

EFSA Journal

Volumn 16, Issue 1, 2018, Pages

  Younes, Maged ^a   Aggett, Peter ^a   Aguilar, Fernando ^a   Crebelli, Riccardo ^a   Filipič, Metka ^a   Frutos, Maria Jose ^a   Galtier, Pierre ^a   Gott, David ^a   Gundert Remy, Ursula ^a   Kuhnle, Gunter Georg ^a   Lambré, Claude ^a   Leblanc, Jean Charles ^a   Lillegaard, Inger Therese ^a   Moldeus, Peter ^a   Mortensen, Alicja ^a   Oskarsson, Agneta ^a   Stankovic, Ivan ^a   Waalkens Berendsen, Ine ^a   Woutersen, Rudolf Antonius ^a   Andrade, Raul J ^a   Fortes, Cristina ^a   Mosesso, Pasquale ^a   Restani, Patrizia ^a   Pizzo, Fabiola ^a   Smeraldi, Camilla ^a   Papaioannou, Adamantia ^a   Wright, Matthew ^a   more..

^a NONE

Author keywords

bowel function; carcinogenicity; colorectal cancer; food supplements; genotoxicity; hydroxyanthracene derivatives; laxatives

Indexed keywords

EID: 85059057271     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2018.5090     Document Type: Review

References (154)

1. Ahlawat KS and Khatkar BS, 2011. Processing, food applications and safety of aloe vera products: a review. Journal of Food Science and Technology, 48, 525–533.
2. Arvindekar AU, Pereira GR and Laddha KS, 2015. Assessment of conventional and novel extraction techniques on extraction efficiency of five anthraquinones from Rheum emodi. Journal of Food Science and Technology, 52, 6574–6582.
3. Bachmann M and Schlatter C, 1981. Metabolism of [14C]emodin in the rat. Xenobiotica, 11, 217–225.
4. Berg I, Forsythe I, Holt P and Watts J, 1983. A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry, 24, 543–549.
5. BfR, 2017. Food supplements with whole-leaf Aloe preparations containing anthranoids are associated with health risks. BfR Opinion No. 032/2017 of 2 November 2017. https://doi.org/10.17590/20171108-091347
6. Bhosle D, Janghel A, Deo S, Raut P, Verma C, Kumar SS, Agrawal M, Amit N, Sharma M, Giri T and Tripathi DK, 2015. Emerging Ultrasound Assisted Extraction (UAE) Techniques as Innovative Green Technologies for the effective extraction of the active phytopharmaceuticals. Research Journal of Pharmacy and Technology, 8, 963–970.
7. Bi S, Song D, Kan Y, Xu D, Tian Y, Zhou X and Zhang H, 2005. Spectroscopic characterization of effective components anthraquinones in Chinese medicinal herbs binding with serum albumins. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy., 62, 203–212.
8. Boudreau MD, Mellick PW, Olson GR, Felton RP, Thorn BT and Beland FA, 2013. Clear evidence of carcinogenic activity by a whole-leaf extract of Aloe barbadensis miller (aloe vera) in F344/N rats. Toxicological sciences, 131, 26–39.
9. Brown JP and Brown RJ, 1976. Mutagenesis by 9,10-anthraquinone derivatives and related compounds in Salmonella typhmurium. Mutation Research/Genetic Toxicology, 40, 203–224.
10. Burlinson B, Tice RR, Speit G, Agurell E, Brendler-Schwaab SY, Collins AR, Escobar P, Honma M, Kumaravel TS, Nakajima M, Sasaki YF, Thybaud V, Uno Y, Vasquez M and Hartmann A; In Vivo Comet Assay Workgroup, part of the Fourth International Workgroup on Geno, 2007. Fourth International Workgroup on Genotoxicity testing: results of the in vivo comet assay workgroup (in Nesslany et al., 2009 Aloe-emodin-induced DNA fragmentation in the mouse in vivo comet assay). Mutation research, 627:31–35.
11. Caldwell DJ, 1999. Review of mononuclear cell leukemia in F-344 rat bioassays and its significance to human cancer risk: A case study using alkyl phthalates. Regulatory toxicology and pharmacology, 30, 45–53.
12. Cameron BD, Phillips MW and Fenerty CA, 1988. Milk transfer of rhein in the rhesus monkey. Pharmacology, 36(Suppl 1), 221–225.
13. Cao W, Yi L, Ye LH, Cao J, Hu SS, Xu JJ, Peng LQ, Zhu QY and Zhang QY, 2015. Application of a highly sensitive magnetic solid phase extraction for phytochemical compounds in medicinal plant and biological fluids by ultra-high performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry. Electrophoresis, 36, 2404–2412.
14. Chandegara VK and Varshney AK, 2013. Aloe vera L. processing and products: a review. International Journal of Medicinal Aromatic Plants, 3, 492–506.
15. Chang XL, Wang C, Feng Y and Liu Z, 2006. Effects of heat treatments on the stabilities of polysaccharides substances and barbaloin in gel juice from Aloe vera Miller. Journal of Food Engineering, 75, 245–251.
16. Che QM, Akao T, Hattori M, Tsuda Y, Namba T and Kobashi K, 1991. Barbaloin stimulates growth of Eubacterium sp. strain BAR, a barbaloin-metabolizing bacterium from human feces. Chemical and pharmaceutical bulletin, 39, 757–760.
17. Chen YY, Chiang SY, Lin JG, Yang JS, Ma YS, Liao CL, Lai TY, Tang NY and Chung JG, 2010. Emodin, aloe-emodin and rhein induced DNA damage and inhibited DNA repair gene expression in SCC-4 human tongue cancer cells. Anticancer research, 30, 945–951.
18. Chesis PL, Levi DE, Smith ML, Emster L and Ames BN, 1984. Mutagenicity of quinones: pathways of metabolic activation and detoxication. Proceedings of the National Academy of Sciences, 81, 1696–1700.
19. Chewchinda S, Wuthi-udomlert M and Gritsanapan W, 2013. HPLC quantitative analysis of rhein and antidermatophytic activity of Cassia fistula pod pulp extracts of various storage conditions. BioMed research international, 19, 2013.
20. Choche T, Shende S and Kadu P, 2014. Extraction and identification of bioactive components from Aloe barbadensis Miller. Journal of Pharmacognosy and Phytochemistry, 2, 14–23.
21. Citronberg J, Kantor ED, Potter JD and White E, 2014. A prospective study of the effect of bowel movement frequency, constipation, and laxative use on colorectal cancer risk. American Journal of Gastroenterology, 109, 1640–1649.
22. Dahms M, Lotz R, Lang W, Renner U, Bayer E and Spahn-Langguth H, 1997. Elucidation of phase I and phase II metabolic pathways of rhein: species differences and their potential relevance. Drug metabolism and disposition, 25, 442–452.
23. Dahshan A, Lin CH, Peters J, Thomas R and Tolia V, 1999. A randomized, prospective study to evaluate the efficacy and acceptance of three bowel preparations for colonoscopy in children. The American Journal of Gastroenterology, 94, 3497–3501.
24. De Witte P and Lemli J, 1988a. 1988b Excretion and distribution of [14C]rhein and [14C]rhein anthrone in rat. Journal of pharmacy and pharmacology, 40, 652–655.
25. De Witte P and Lemli J, 1988b. Metabolism of 14C-rhein and 14C-rhein anthrone in rats. Pharmacology, 36(Suppl. 1), 152–157.
26. De Witte P, Cuveele J and Lemli J, 1992. In vitro deterioration of rhein anthraquinone in cecal content of rats. Pharmaceutica acta Helvetiae, 67, 198–203.
27. Dhodare GD, Wandhare GD, Jirapure MN and Dumore NS, 2015. Extraction of aloin from aloevera by using soxhlet apparatus. International Journal For Engineering Applications and Technology, ISSN: 2321-8134
28. Ding WJ, Wu XF, Zhong JS and Wan JZ, 2014. Effects of temperature, pH and light on the stability of aloin A and characterisation of its major degradation products. International journal of food science & technology, 49, 1773–1779.
29. Donfack AR, Tala MF, Wabo HK, Jerz G, Zeng GZ, Winterhalter P, Tan NH and Tane P, 2014. Two new anthraquinone dimers from the stem bark of Pentas schimperi (Rubiaceae). Phytochemistry Letters, 31, 55–58.
30. Doull J, Bridges BA, Kroes R, Golberg L, Munro IC, Paynter OE, Pitot HC, Squire R, Williams GM and Darby WJ, 1983. The Relevance of Mouse Liver Hepatoma to Human Carcinogenic Risk: A Report of the International Expert Advisory Committee to the Nutrition Foundation. The Nutrition Foundation, Washington.
31. Dukas L, Willett WC, Colditz GA, Fuchs CS, Rosner B and Giovannucci EL, 2000. Prospective study of bowel movement, laxative use, and risk of colorectal cancer among women. American Journal of Epidemiology, 151, 958–964.
32. Duval J, Pecher V, Poujol M and Lesellier E, 2016. Research advances for the extraction, analysis and uses of anthraquinones: A review. Industrial Crops and Products, 94, 812–833.
33. EFSA (European Food Safety Authority), 2009. Guidance of the Scientific Committee on Transparency in the Scientific Aspects of Risk Assessments carried out by EFSA. Part 2: General Principles. EFSA Journal 2009;5(5):1051, 22 pp. https://doi.org/10.2903/j.efsa.2009.1051
34. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2013. Scientific Opinion on the substantiation of a health claim related to hydroxyanthracene derivatives and improvement of bowel function pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 2013;11(10):3412, 12 pp. https://doi.org/10.2903/j.efsa.2013.3412
35. EFSA Scientific Committee, 2009. Guidance on safety assessment of botanicals and botanical preparations intended for use as ingredients in food supplements, on request of EFSA. EFSA Journal 2009;7(9):1249, 19 pp. https://doi.org/10.2093/j.efsa.2009.1249
36. EFSA Scientific Committee, 2012. Guidance on selected default values to be used by the EFSA Scientific Committee, Scientific Panels and Units in the absence of actual measured data. EFSA Journal 2012;10(3):2579, 32 pp. https://doi.org/10.2903/j.efsa.2012.2579
37. EMA (European Medicines Agency), 2006. Community Herbal Monograph on Aloe barbadensis Miller and on Aloe (Various Species, Mainly Aloe Ferox Miller and Its Hybrids). EMA, London.
38. EMA (European Medicines Agency), 2007a. Committee on herbal medicinal products. Assessment report on Aloe barbadensis miller and aloe (various species, mainly aloe ferox Miller and its hybrids). Available online: http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2009/12/WC500017830.pdf
39. EMA (European Medicines Agency), 2007b. Committee on herbal medicinal products. Assessment report on Rhamnus frangula l., cortex. Available online: http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2009/12/WC500018613.pdf
40. EMA (European Medicines Agency), 2007c. Committee on herbal medicinal products. Assessment report on Cassia senna L. and Cassia angustifolia Vahl, folium. Available online: http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2009/12/WC500018219.pdf
41. EMA (European Medicines Agency), 2007d. Committee on herbal medicinal products. Assessment report on Cassia senna L., fructus and Cassia angustifolia Vahl, fructus. Available online: http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2009/12/WC500018206.pdf
42. EMA (European Medicines Agency), 2008a. Assessment report for Rhubarb (Rhei radix). Available online: http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2009/12/WC500018404.pdf
43. EMA (European Medicines Agency), 2008b. Assessment Report: Rhamnus purshianus d.c.; Rhamni purshianae cortex; Cascara and herbal preparation(s) thereof with well-established use and traditional use. Available online: http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2009/12/WC500018426.pdf
44. EMA (European Medicines Agency), 2017a. Committee on Herbal Medicinal Products (HMPC). Assessment report on Aloe barbadensis Mill. and on Aloe (various species, mainly Aloe ferox Mill. and its hybrids), folii succus siccatus. Available online: http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2009/12/WC500017830.pdf
45. EMA (European Medicines Agency), 2017b. EMA, Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Senna alexandrina Mll. (Cassia senna L.; Cassia angustifolia Vahl), fructus. Revised draft document, currently under consultation. Available on line: http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2017/10/WC500236598.pdf
46. Faber P and Strenge-Hesse A, 1988. Relevance of rhein extraction into breast milk. Pharmacology, 36(Suppl 1), 212–220.
47. Goppel M and Franz G, 2004. Stability control of senna leaves and senna extracts. Planta Medica, 70, 432–436.
48. Gordon M, Naidoo K, Akobeng AK and Thomas AG, 2013. Osmotic and stimulant laxatives for the management of childhood constipation (Review). Evidence-Based Child Health: A Cochrane Review Journal, 8, 57–109.
49. Gulia A, Sharma HK, Sarkar BC, Upadhyay A and Shitandi A, 2010. Changes in physico-chemical and functional properties during convective drying of aloe vera (Aloe barbadensis) leaves. Food and Bioproducts Processing, 88, 161–164.
50. Guo X, Zhang S, Dial SL, Boudreau MD, Xia Q, Fu PP, Levy DD, Moore MM and Mei N, 2014. In vitro investigation of the mutagenic potential of Aloe vera extracts. Toxicology Research, 3, 487.
51. Harada T, Enomoto A, Boorman GA and Maronpot RR, 1999. Chapter 7: Liver and gallbladder. In: Maronpot RR (ed.). Pathology of the Mouse. Reference and Atlas, 1st Edition. Library of Congress Catalog Card Number 98-74814. ISBN 1-889899-03-8.
52. Hartmann A, Agurell E, Beevers C, Brendler-Schwaab S, Burlinson B, Clay P, Collins A, Smith A, Speit G, Thybaud V and Tice RR, 2003. Recommendations for conducting the in vivo alkaline comet assay (in Nesslany et al., 2009 Aloe-emodin-induced DNA fragmentation in the mouse in vivo comet assay). Mutagenesis, 18, 45–51. Available here: https://www.ncbi.nlm.nih.gov/pubmed/12473734
53. Hattori M, Namba T, Akao T and Kobashi K, 1988. Metabolism of sennosides by human intestinal bacteria. Pharmacology, 36, 172–179.
54. Haverkamp W, Monnig G, Schulze-Bahr E, Haverkamp F and Breithardt G, 2002. Physician-induced torsade de pointes—therapeutic implications. Cardiovascular Drugs and Therapy, 16, 101–109.
55. Heidemann A, Miltenburger HG and Mengs U, 1993. The genotoxicity status of senna. Pharmacology, 47, 178–186.
56. Heidemann A, Voelkner W and Mengs U, 1996. Genotoxicity of aloeemodin in vitro and in vivo. Mutation Research/Genetic Toxicology, 367, 123–133.
57. IARC, 1990. IARC Monograph on DANRON (CHRYSAZIN;1,8-DIHYROXYANTHRQUINONE) 1990, 50, pp. 265–275.
58. IARC, 2016. IARC MONOGRAPHS: Some Drugs and Herbal Products, Vol. 108. IARC, Lyon, France.
59. IASC, 2009. IASC Labeling Guidance and Definitions document. Available online: http://www.iasc.org/Portals/19/Documents/Members/10_0405_IASC_Labeling_Guidance_Definitions.pdf
60. IASC (International Aloe Science Council), online. Available online: http://www.iasc.org/Portals/19/Documents/Scientific/16_0531_Decolorization_statement_final.pdf?ver=2016-05-31-163902-973
61. Jacobs EJ and White E, 1998. Constipation, laxative use, and colon cancer among middle-aged adults. Epidemiology, 9, 385–391.
62. Jawade NR and Chavan AR, 2013. Ultrasonic-assisted extraction of aloin from aloe vera gel. Procedia Engineering, 51, 487–493. doi:10.1016/j.proeng.2013.01.069
63. JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2000. Guidelines for the preparation of toxicological working papers for the Joint FAO/WHO Expert Committee on Food Additives. Geneva, Switzerland.
64. Kierkus J, Horvath A, Szychta M, Woynarowski M, Wegner A, Wiernicka A, Dadalski M, Teisseyre M and Dziechciarz P, 2013. High-versus low-volume polyethylene glycol plus laxative versus sennosides for colonoscopy preparation in children. Journal of pediatric gastroenterology and nutrition, 57, 230–235.
65. Kojima M, Wakai K, Tokudome S, Tamakoshi K, Toyoshima H, Watanabe Y, Hayakawa N, Suzuki K, Hashimoto S, Ito Y and Tamakoshi A; JACC Study Group, 2004. Bowel movement frequency and risk of colorectal cancer in a large cohort study of Japanese men and women. British Journal of Cancer, 90, 1397–13401.
66. Konsensuspapier expertenforum, 1999. Obstipation und Laxanzien.
67. Krumbiegel G and Schulz HU, 1993. Rhein and aloe-emodin kinetics from senna laxatives in man. Pharmacology, 47, 120–124.
68. Kune GA, 1993. Laxative use not a risk for colorectal cancer: data from the Melbourne Colorectal Cancer Study. Zeitschrift fur Gastroenterologie, 31, 140–143.
69. Kune GA, Kune S, Field B and Watson LF, 1988. The role of chronic constipation, diarrhea, and laxative use in the etiology of large-bowel cancer. Diseases of the colon & rectum, 31, 507–512.
70. Lainonen H, Marvola M, Hietala P and Parviainen T, 1988. The effect of different storage conditions on the chemical stability, laxative effect and acute toxicity of sennoside solutions. Pharmacology and Toxicology, 63, 37–41.
71. Lang W, 1988. Pharmacokinetics of 14C-labelled rhein in rats. Pharmacology, 36(Suppl 1), 158–171.
72. Lang W, 1993. Pharmacokinetic-metabolic studies with 14C-aloe emodin after oral administration to male and female rats. Pharmacology, 47(Suppl 1), 110–119.
73. Lee JH, Kim JM and Kim C. Pharmacokinetic analysis of rhein in Rheum undulatum L. Journal of ethnopharmacology 2003;84:5–9.
74. Levi DE, Hollstein M, Chritman ME and Ames RN, 1984. Detection of oxidative mutagens with a new Salmonella tester strain (fA102). Methods in Enzymology, 105, 249–254.
75. Lewis SJ, Heaton KW, Oakey RE and McGarrigle HH, 1997. Lower serum oestrogen concentrations associated with faster intestinal transit. British Journal of Cancer, 76, 395–400.
76. Li Y, Luan Y, Qi X, Li M, Gong L, Xue X, Wu X, Wu Y, Chen M, Xing G and Yao J, 2010. Emodin triggers DNA double-strand breaks by stabilizing topoisomerase II-DNA cleavage complexes and by inhibiting ATP hydrolysis of topoisomerase II. Toxicological Sciences, 118, 435–443.
77. Liang J, Hsiu S, Wu P and Chao P, 1995. Emodin pharmacokinetics in rabbits. Planta Medica, 61, 406–408.
78. Liberman DE, Fink RC, Schaefer EL, Mulcahy RJ and Stark A-A, 1982. Mutagenicity of anthraquinone and hydroxylated anthraquinones in the Ames/Salmonella microsome system. Applied and Environment Microbiology, 43, 1354–1359.
79. Lin ML, Chen SS, Lu YC, Liang RY, Ho YT, Yang CY and Chung JG, 2007. Rhein induces apoptosis through induction of endoplasmic reticulum stress and Ca2 + -dependent mitochondrial death pathway in human nasopharyngeal carcinoma cells. Anticancer Research, 27, 3313–3322.
80. Liu W, Tang L, Ye L, Cai Z, Xia B, Zhang J, Hu M and Liu Z, 2010. Species and gender differences affect the metabolism of emodin via glucuronidation. The AAPS Journal, 12, 424–436.
81. Locatelli M, Genovese S, Carlucci G, Kremer D, Randic M and Epifano F, 2012. Development and application of high-performance liquid chromatography for the study of two new oxyprenylated anthraquinones produced by Rhamnus. Journal of Chromatography A, 1225, 113–120.
82. Lu C, Wang H, Lv W, Ma C, Xu P, Zhu J, Xie J and Zhou Q, 2011. Ionic liquid-based ultrasonic/microwave-assisted extraction combined with UPLC for the determination of anthraquinones in Rhubarb. Chromatographia, 74, 139–144.
83. Lydén-Sokolowski A, Nilsson A and Sjöberg P, 1993. Two-year carcinogenicity study with sennosides in the rat: Emphasis on gastro-intestinal alterations. Pharmacology, 47(Suppl 1), 209–215.
84. Maekawa A and Odashima S, 1975. Spontaneous tumors in ACI/Nrats. Journal of the National Cancer Institute, 55, 1437–1445.
85. Martínez-Costa C, Palao Ortuño MJ, Alfaro Ponce B, Núñez Gómez F, Martínez-Rodríguez L, Ferré Franch I and Brines Solanes J, 2005. Functional constipation: prospective study and treatment response. Anales de Pediatría, 63, 418–425.
86. Mascolo N, Mereto E, Borrelli F, Orsi P, Sini D, Izzo AA, Massa B, Boggio M and Capasso F, 1999. Does senna extract promote growth of aberrant crypt foci and malignant tumors in rat colon? Digestive Diseases and Sciences, 44, 2226–2230.
87. Matsuda Y, Yokohira M, Suzuki S, Hosokawa K, Yamakawa K, Zeng Y, Ninomiya F, Saoo K, Kuno T and Imaida K, 2008. One-year chronic toxicity study of Aloe arborescens Miller var. natalensis Berger in Wistar Hannover rats. A pilot study. Food and Chemical Toxicology, 46, 733–739.
88. Mehta N and Laddha KS, 2009. A modified method for isolation of rhein from senna. Indian Journal of Pharmaceutical Sciences, 71, 128–129.
89. Mengs U and Heidemann A, 1993. Genotoxicity of sennosides and rhein in vitro and in vivo. Medical science research, 21, 749–750.
90. Mengs U, Krumbiegel G and Völkner W, 1997. Lack of emodin genotoxicity in the mouse micronucleus assay. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 393, 289–293.
91. Mengs U, Grimminger W, Krumbiegel G, Schuler D, Silber W and Völkner W, 1999. No clastogenic activity of a senna extract in the mouse micronucleus assay. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 444, 421–426.
92. Mengs U, Schuler D and Marshall RR, 2001. No induction of chromosomal aberrations in Chinese hamster ovary cells by chrysophanol. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 492, 69–72.
93. Miranda M, Maureira H, Rodríguez K and Vega-Gálvez A, 2009. Influence of temperature on the drying kinetics, physicochemical properties, and antioxidant capacity of Aloe Vera (Aloe Barbadensis Miller) gel. Journal of Food Engineering, 91, 297–304.
94. Mitchell JM, Mengs U, McPherson S, Zijlstra J, Dettmar P, Gregson R and Tigner JC, 2006. An oral carcinogenicity and toxicity study of senna (Tinnevelly senna fruits) in the rat. Archives of toxicology, 80, 34–44.
95. Mori H, Sugie S, Niwa K, Takahashi M and Kawai K, 1985. Induction of intestinal tumours in rats by chrysazin. British Journal of Cancer, 52, 781–783.
96. Mori H, Sugie S, NIwA K, Yoshimi N, Tanaka T and Hirono I, 1986. Carcinogenicity of chrysazin in large intestine and liver of mice. Japanese Journal of Cancer Research Gann, 77, 871–876.
97. Morimoto I, Watanabe F, Osawa T, Okitsu T and Kada T, 1982. Mutagenicity screening of crude drugs with Bacillus subtilis rec-assay and Salmonella/microsome reversion assay. (in Williams et al., 2010 Safety studies conducted on a proprietary high-purity aloe vera inner leaf fillet preparation, Qmatrix). Mutation Research/Environmental Mutagenesis and Related Subjects, 97, 81–102.
98. Mueller SO and Stopper H, 1999. Characterization of the genotoxicity of anthraquinones in mammalian cells. Biochimica et Biophysica Acta, 1428, 406–414.
99. Mueller SO, Eckert I, Lutz WK and Stopper H, 1996. Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: Topoisomerase II mediated? Mutation Research, 371, 165–173.
100. Nesslany F, Simar-Meintières S, Ficheux H and Marzin D, 2009. Aloe-emodin-induced DNA fragmentation in the mouse in vivo comet assay. Mutation Research, 678, 13–19.
101. Nolan T, Debelle G, Oberklaid F and Coffey C, 1991. Randomised trial of laxatives in treatment of childhood encopresis. Lancet, 338, 523–527.
102. NTP, 2001. NTP technical report on the toxicology and carcinogenesis studies of emodin (CAS NO. 518-82-1) in F344/N rats and B6C3F1 mice (feed studies).
103. NTP, 2013. NTP technical report on the toxicology and carcinogenesis studies of a nondecolorized whole leaf extract of aloe barbadensis miller (aloe vera) in F344/N rats and B6C3F1 mice (drinking water studies).
104. Nusko G, Schneider B, Müller G, Kusche J and Hahn EG, 1993. Retrospective study on laxative use and melanosis coli as risk factors for colorectal neoplasma. Pharmacology, 47(Suppl 1):234–241.
105. Nusko G, Schneider B, Schneider I, Wittekind C and Hahn EG, 2000. Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study. Gut, 46, 651–655.
106. Olennikov DN, Zilfikarov IN, Ibragimov TA, Toropova AA and Tankhaeva LM, 2010. Chemical composition and antioxidative activity (in vitro) of arborescent aloe juice (Aloe Arborescens Mill. Chemistry, 3, 83–90.
107. Paes-Leme AA, Motta ES, De Mattos JC, Dantas FJ, Bezerra RJ and Caldeira-de-Araujo A, 2005. Assessment of Aloe vera (L.) genotoxic potential on Escherichia coli and plasmid DNA. Journal of Ethnopharmacology, 102, 197–201.
108. Park JY, Mitrou PN, Luben R, Khaw KT and Bingham SA, 2009. Is bowel habit linked to colorectal cancer? - Results from the EPIC-Norfolk study. European Journal of Cancer, 45, 139–145.
109. Pellizzoni M, Molinari GP and Lucini L, 2011. Stability of the main Aloe fractions and Aloe-based commercial products under different storage conditions. Agrochimica, 55, 288–296.
110. Perkin J, 1977. Constipation in childhood: A controlled comparison between lactulose and standard senna. Current Medical Research and Opinion, 4, 540–543.
111. Pongnaravane B, Goto M, Sasaki M, Anekpankul T, Pavasant P and Shotipruk A, 2006. Extraction of anthraquinones from roots of Morinda citrifolia by pressurized hot water: Antioxidant activity of extracts. The Journal of supercritical fluids, 37, 390–396.
112. Rahman S, Carter P and Bhattarai N, 2017. Aloe vera for tissue engineering applications. Journal of Functional Biomaterials, 8, pii: E6
113. Ramachandra CT and Rao PS, 2013. Shelf-life and colour change kinetics of Aloe vera gel powder under accelerated storage in three different packaging materials. Journal of food science and technology, 50, 747–754.
114. Roberts MC, Millikan RC, Galanko JA, Martin C and Sandler RS, 2003. Constipation, laxative use, and colon cancer in a North Carolina population. American Journal of Gastroenterology, 98, 857–864.
115. Sakulpanich A and Gritsanapan W, 2008. Extraction method for high content of anthraquinones from Cassia fistula pods. Journal of Health Research, 22, 167–172.
116. Sehgal I, Winters WD, Scott M, David A, Gillis G, Stoufflet T, Nair A and Kousoulas K, 2013. Toxicologic assessment of a commercial decolorized whole leaf aloe vera juice, lily of the desert filtered whole leaf juice with aloesorb. Journal of Toxicology, 11, 2013.
117. Shamsipur M, Fasihi J, Khanchi A, Yamini Y, Valinezhad A and Sharghi H, 2008. Solubilities of some 9, 10-anthraquinone derivatives in supercritical carbon dioxide: A cubic equation of state correlation. The Journal of Supercritical Fluids, 47, 154–160.
118. Shi Z, Zhu X, Cheng Q and Zhang H, 2007. Micellar Extraction and Preconcentration of Anthraquinone Derivatives from Rhubarb Prior to Their HPLC-DAD Determination. Journal of liquid chromatography & related technologies, 30, 255–271.
119. Shi YB, Li HL, Wang HQ, Yang YB, Zhang XY, Wang H, Zhu ZJ, Zhang ZY and Zhang CA, 2014. Simultaneous determination of five anthraquinones in a Chinese traditional preparation by RP-HPLC using an improved extraction procedure. Journal of Integrative Medicine, 12, 455–462.
120. Shia CS, Tsai SY, Lin JC, Li ML, Ko MH, Chao PD, Huang YC and Hou YC, 2011. Steady-state pharmacokinetics and tissue distribution of anthraquinones of Rhei Rhizoma in rats. Journal of ethnopharmacology, 137, 1388–1394.
121. Siegers CP, Siemers J and Baretton G, 1993. Sennosides and aloin do not promote dimethylhydrazine-induced colorectal tumors in mice. Pharmacology, 47(Suppl. 1), 205–208.
122. Sitzmann FC, 1979. Lokale Nebenwirkungen an der Haut durch Anthraglykoside. Pädiatr Prax, 21, 355–358.
123. Sondheimer J and Gervaise E, 1982. Lubricant versus laxative in the treatment of chronic functional constipation of children: A comparative study. Journal of Pediatric Gastroenterology and Nutrition, 1, 223–226.
124. Song R, Lin H, Zhang Z, Li Z, Xu L, Dong H and Tian Y, 2009. Profiling the metabolic differences of anthraquinone derivatives using liquid chromatography/tandem mass spectrometry with data-dependent acquisition. Rapid Communications in Mass Spectrometry, 23, 537–547.
125. Sonnenberg A and Müller AD, 1993. Constipation and cathartics as risk factors of colorectal cancer: a meta-analysis. Pharmacology, 47(Suppl. 1), 224–233.
126. Srikanth S, Kumar VS, Kiran RS, Prasad MV and Krishnamohan G, 2011. Microwave assisted extraction of calcium sennosides from senna leaflets. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 2, 137–145.
127. Su SC and Ferguson NM, 1973. Extraction and separation of anthraquinone glycosides. Journal of pharmaceutical sciences, 62, 899–901.
128. Sund RB and Elvegård SO, 1988. Anthraquinone laxatives: metabolism and transport of danthron and rhein in the rat small and large intestine in vitro. Pharmacology, 36(Suppl. 1), 144–151.
129. Surh I, Brix A, French JE, Collins BJ, Sanders JM, Vallant M and Dunnick JK, 2013. Toxicology and carcinogenesis study of senna in C3B6. 129F1-Trp53 tm1Brd N12 haploinsufficient mice. Toxicologic pathology, 41, 770–778.
130. Takizawa Y, Morota T, Takeda S and Aburada M, 2003. Pharmacokinetics of rhein from Onpi-to, an oriental herbal medicine, in rats. Biological and Pharmaceutical Bulletin, 26, 613–617.
131. Tan Z, Li F and Xu X, 2012. Isolation and purification of aloe anthraquinones based on an ionic liquid/salt aqueous two-phase system. Separation and Purification Technology, 19, 150–157.
132. Tan ZJ, Li FF and Xu XL, 2013. Extraction and purification of anthraquinones derivatives from Aloe vera L. using alcohol/salt aqueous two-phase system. Bioprocess and biosystems engineering, 36, 1105–1113.
133. Terry NA, Chen-Lim ML, Ely E, Jatla M, Ciavardone D, Esch S, Farace L, Jannelli F, Puma A, Carlow D and Mamula P, 2013. Polyethylene glycol powder solution versus senna for bowel preparation for colonoscopy in children. Journal of pediatric gastroenterology and nutrition, 56, 215–219.
134. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC and Sasaki YF, 2000. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing (in Nesslany et al., 2009 Aloe-emodin-induced DNA fragmentation in the mouse in vivo comet assay). Environmental and molecular mutagenesis, 35, 206–221.
135. Tikkanen L, Matsushima T and Natori S, 1983. Mutagenicity of anthraquinones in the Salmonella preincuabation test. Mutation Research, 116, 297–304.
136. Vargas F, Fraile G, Velasquez M, Correia H, Fonseca G, Marin M, Marcano E and Sanchez Y, 2002. Studies on the photostability and phototoxicity of aloe-emodin, emodin and rhein. Die Pharmazie, 57, 399–404.
137. Vázquez MB, Comini LR, Milanesio JM, Montoya SN, Cabrera JL, Bottini S and Martini RE, 2015. Pressurized hot water extraction of anthraquinones from Heterophyllaea pustulata Hook f. (Rubiaceae). The Journal of Supercritical Fluids, 30, 170–175.
138. Waltenberger B, Avula B, Ganzera M, Khan IA, Stuppner H and Khan SI, 2008. Transport of sennosides and sennidines from Cassia angustifolia and Cassia senna across Caco-2 monolayers–an in vitro model for intestinal absorption. Phytomedicine, 15, 373–377.
139. Wang L, Li D, Bao C, You J, Wang Z, Shi Y and Zhang H, 2008. Ultrasonic extraction and separation of anthraquinones from Rheum palmatum L. Ultrasonics sonochemistry, 15, 738–746.
140. Watanabe T, Nakaya N, Kurashima K, Kuriyama S, Tsubono Y and Tsuji I, 2004. Constipation, laxative use and risk of colorectal cancer: the Miyagi Cohort Study. European Journal of Cancer, 40, 2109–2115.
141. Westendorf J, Marquardt H, Poginsky B, Dominiak M, Schmidt J and Marquardt H, 1990. Genotoxicity of naturally occurring hydroxyanthraquinones. Mutation Research/Genetic Toxicology, 240, 1–2.
142. Williams LD, Burdock GA, Shin E, Kim S, Jo TH, Jones KN and Matulka RA, 2010. Safety studies conducted on a proprietary high-purity aloe vera inner leaf fillet preparation, Qmatrix®. Regulatory Toxicology and Pharmacology, 57, 90–98.
143. Witte P and Lemli L, 1990. The metabolism of anthranoid laxatives. Hepato-gastroenterology, 37, 601–605.
144. World Health Organization, 1999. WHO Monographs On Selected Medicinal Plants, Vol. 1. World Health Organization, Geneva.
145. Wu W, Yan R, Yao M, Zhan Y and Wang Y, 2014a. Pharmacokinetics of anthraquinones in rat plasma after oral administration of a rhubarb extract. Biomedical Chromatography, 28, 564–572.
146. Wu W, Hu N, Zhang Q, Li Y, Li P, Yan R and Wang Y, 2014b. In vitro glucuronidation of five rhubarb anthraquinones by intestinal and liver microsomes from humans and rats. Chemico-biological interactions, 5, 18–27.
147. Yang X, Liang X, Yang L, Pan F, Deng F and Liu H, 2014. Novel gas-assisted three-liquid-phase extraction system for simultaneous separation and concentration of anthraquinones in Herbal Extract. Chinese Journal of Chemical Engineering, 22, 968–973.
148. Yokohira M, Matsuda Y, Suzuki S, Hosokawa K, Yamakawa K, Hashimoto N, Saoo K, Nabae K, Kuno T and Imaida K, 2009. Equivocal colonic carcinogenicity of aloe arborescens miller var. natalensis berger at high-dose level in a wistar Hannover rat 2-y study. Journal of food science, 74, 24–30.
149. Yu, et al., 2016. Species and gender differences affect the metabolism of emodin via glucuronidation.
150. Yu C-P, Shia C-S, Lin H-J, Hsieh Y-W, Lin S-P and Hou Y-C, 2016. Analysis of the pharmacokinetics and metabolism of aloe-emodin following intravenous and oral administrations in rats. Biomedical Chromatography, 30, 1641–1647.
151. Zhang Z, Fu J, Yao B, Zhang X, Zhao P and Zhou Z, 2011. In vitro genotoxicity of danthron and its potential mechanism. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 722, 39–43.
152. Zhang X, Wu K, Cho E, Ma J, Chan AT, Gao X, Willett WC, Fuchs CS and Giovannucci EL, 2013. Prospective cohort studies of bowel movement frequency and laxative use and colorectal cancer incidence in US women and men. Cancer Causes & Control, 24, 1015–1024.
153. Zhao LC, Liang J, Li W, Cheng KM, Xia X, Deng X and Yang GL, 2011. The use of response surface methodology to optimize the ultrasound-assisted extraction of five anthraquinones from Rheum palmatum L. Molecules, 16, 5928–5937.
154. Zhao F, Zhao S, Han JT, Wang YF, Wang YN and Wang CH, 2015. Antiviral anthraquinones from the roots of Knoxia valerianoides. Phytochemistry Letters, 31, 57–60.